Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cannon

Showing results (811-820 of 837) with videos related to

Pageof 84
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Cognition and Electrophysiology Clustering in Clinical High Risk for Psychosis Delineates Distinct Dimensions of Heterogeneity: Implications for Multimodal ClusteringWalid Yassin, James B Green, Michael Cai, et al.
Human Brain Mapping|August 29, 2013
Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosisTyrone D Cannon, Frank Sun, Sarah Jacobson McEwen, et al.
Molecular Psychiatry|May 24, 2021
White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosisMaria A Di Biase, Suheyla Cetin-Karayumak, Amanda E Lyall, et al.
The New England Journal of Medicine|March 23, 2022
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 VaccineEdson D Moreira, Nicholas Kitchin, Xia Xu, et al.
Biological Psychiatry|September 6, 2021
Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA CohortNikolaos Koutsouleris, Michelle Worthington, Dominic B Dwyer, et al.
American Journal of Hematology|July 2, 2024
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot studyJames F Casella, Dana K Furstenau, Robert J Adams, et al.
Schizophrenia Bulletin|January 20, 2024
Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development StudyJonah F Byrne, Colm Healy, Melanie Föcking, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Fetal Gene Regulatory Gene Deletions are Associated with Poor Cognition and Altered Cortical Morphology in Schizophrenia and Community-Based SamplesJennifer K Forsyth, Jinhan Zhu, Ariana S Chavannes, et al.
Schizophrenia Research|May 14, 2020
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefitScott W Woods, Carrie E Bearden, Fred W Sabb, et al.
Cancer Research|May 5, 2026
Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic CancerKylie Belanger, Samantha Guinn, Brayan Perez, et al.
Pageof 84

Showing results (811-820 of 837) with videos related to

Sort By:
Pageof 84
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
Cognition and Electrophysiology Clustering in Clinical High Risk for Psychosis Delineates Distinct Dimensions of Heterogeneity: Implications for Multimodal ClusteringWalid Yassin, James B Green, Michael Cai, et al.
Human Brain Mapping|August 29, 2013
Reliability of neuroanatomical measurements in a multisite longitudinal study of youth at risk for psychosisTyrone D Cannon, Frank Sun, Sarah Jacobson McEwen, et al.
Molecular Psychiatry|May 24, 2021
White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosisMaria A Di Biase, Suheyla Cetin-Karayumak, Amanda E Lyall, et al.
The New England Journal of Medicine|March 23, 2022
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 VaccineEdson D Moreira, Nicholas Kitchin, Xia Xu, et al.
Biological Psychiatry|September 6, 2021
Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA CohortNikolaos Koutsouleris, Michelle Worthington, Dominic B Dwyer, et al.
American Journal of Hematology|July 2, 2024
Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot studyJames F Casella, Dana K Furstenau, Robert J Adams, et al.
Schizophrenia Bulletin|January 20, 2024
Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development StudyJonah F Byrne, Colm Healy, Melanie Föcking, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Fetal Gene Regulatory Gene Deletions are Associated with Poor Cognition and Altered Cortical Morphology in Schizophrenia and Community-Based SamplesJennifer K Forsyth, Jinhan Zhu, Ariana S Chavannes, et al.
Schizophrenia Research|May 14, 2020
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefitScott W Woods, Carrie E Bearden, Fred W Sabb, et al.
Cancer Research|May 5, 2026
Cancer-Associated Fibroblasts Promote Epithelial-Mesenchymal Transition and Classical to Basal Subtype Shift in Pancreatic CancerKylie Belanger, Samantha Guinn, Brayan Perez, et al.
Pageof 84